Nanomaterials-based
immunochromatographic assays (ICAs) have gained
great commercial success in real-life point-of-care testing (POCT).
Exploring novel carriers of ICAs with improved signaling and sustained
activity favors the development of sensitive POCT. Herein a potent
signal biotag, colored Staphylococcus aureus (SA),
was created for ICA carriers through a mild self-assembly strategy,
providing high luminance and abundant specific binding sites for immobilization
of monoclonal antibodies (mAbs). The biocompatible SA-dyes (SADs)
retained both an intact surface structure for mAbs labeling (Fc portion)
and the superior bioactivity of immobilized mAbs (affinity constant
was about 109 M–1), thus waiving the
intrinsic limitations of traditional nanomaterials and endowing high
sensitivity. Proof-of-concept was demonstrated by employing Congo
red- or/and fluorescein isothiocyanate-embedded SA (SACR, SAFITC,
and SACR–SAFITC) as ICA carriers to detect zearalenone (ZEN)
through colorimetric or/and fluorimetric signals. Furthermore, the
ICAs satisfied the clinical requirement perfectly, including limit
of detection (0.013 ng/mL, which was at least an 85-fold improvement
over that of traditional gold nanoparticles-based ICA), linearity
(R
2 > 0.98), reproducibility (RSD <
8%), selectivity, and stability. Importantly, the proposed biosensors
could be well-applied in four real samples for ZEN monitoring with
satisfactory recoveries, correlating well with the results from liquid
chromatography–tandem mass spectrometry (LC-MS). This work
also proved a universal design for tailoring coloration bands for
SAD–ICA detection of multiple analytes.